secwatch.observer — SEC 8-K summary
======================================

Issuer:     IR-Med, Inc. (—)
CIK:        0001839133
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001493152-24-008852
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

IR-Med appoints co-founder Aharon Klein as Interim CEO effective Feb. 28, 2024
------------------------------------------------------------------------------

- Aharon Klein, age 60, currently CTO and co-founder, becomes Interim CEO of IR-Med and its Israeli subsidiary.
- Klein co-founded IR-Med in 2013, served as COO until 2020, then CTO; prior experience includes FertiliGent and a medical device startup.
- Klein continues under same service provider agreement with no disclosed change in compensation terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1839133/000149315224008852/0001493152-24-008852-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1839133/000149315224008852/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-008852

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer